Detailed Mechanism Funding and Narrative

Years of mechanism: 2007 2008 2009

Details for Mechanism ID: 4734
Country/Region: Haiti
Year: 2007
Main Partner: Catholic Relief Services
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/HRSA
Total Funding: $302,679

Funding for Treatment: ARV Drugs (HTXD): $302,679

SUMMARY: The overall goal of the CRS AIDSRelief supply chain is to ensure that the necessary infrastructure, systems and skills are in place for efficient forecasting, procurement, warehousing and distribution of high quality, safe and effective ARVs plus related health supplies to the various sites and the effective monitoring of their use. Target populations include adults, infants, children, and youth infected with HIV, who seek medical services at any AIDSRelief hospital. Emphasis areas include commodity procurement, local organization capacity development, logistics, infrastructure, and training. ARV drug management under AIDSRelief's Haiti program is a continuing activity and was fully funded in FY06. AIDSRelief directly procures ARVs for use within the program through International Dispensary Foundation (IDA) Netherlands, as the procurement agent. AIDSRelief collaborates with the Government of Haiti for the importation of ARVs through Haiti's Customs and Ministry of Health (MOH) departments whose regulations guide the functioning of the pharmaceutical import sector. The drugs imported are according to treatment regimens as specified in national protocols. Management of ARVs under AIDSRelief is made possible through partnership with the World Health Organization (WHO)/Pan America Health Organization (PAHO) PROMESS Program, which also supports other government drug management activities. PROMESS facilitates customs clearance for AIDSRelief drugs, warehousing and distribution.

ACTIVITIES AND EXPECTED RESULTS: Activity 1: AIDSRelief will strengthen local capacity in the area of pharmaceutical management and support. AIDSRelief Haiti has hired a dedicated highly qualified pharmacist whose main responsibility is to support sites to strengthen their pharmacy and supply chain management capacity. Key pharmacy personnel will be individually trained and mentored to strengthen their skills and improve their capabilities in drug forecasting, quantification, ordering, inventory management, drug information management, drug utilization monitoring and rational drug use. Drug dispensing records at each of the eight site pharmacies will be computerized and a dispensing software program installed to track ARVs dispensed. To promote best practices in pharmacy management, key pharmacy staff will visit other sites to exchange lessons learned and adopt best practices. This initiative to improve learning is also part of an overall staff retention strategy. Activity 2: AIDSRelief will make structural improvements at each of the eight hospital facilities in its network to improve drug storage and management of drug stocks. All site pharmacies will be refitted to increase storage space in order to accommodate increased patient scale-up. This process has already begun at Gonaives' Hôpital La Providence, the Ministry of Health's regional hospital for the Artibonite Regional Department, and will be initiated at the other facilities in the AIDSRelief program in FY07. Activity 3: AIDSRelief will collaborate with other stakeholders involved with HIV/AIDS care to improve efficiency. AIDSRelief will work with the USG Team, the Partnership for Supply Chain Managment (PFSCM), the Government of Haiti and PROMESS to strengthen supply chain and pharmacy management capacity of AIDSRelief's sites. Joint training sessions, sharing of materials, joint planning and regular meetings will be undertaken to ensure harmonization of different systems and to ensure that in-country supply chain systems are prioritized, strengthened and that overall pipeline for supply of ARVs continues without interruption. Activity 4: AIDSRelief will provide ARVs of highest quality through its eight clinical facilities. In keeping with PEPFAR's goal of clinical excellence, AIDSRelief will ensure patients uninterrupted access to treatment. As AIDSRelief continues to increase its enrollment, pharmacy management and infrastructure will be prepared to accommodate program expansion. The ARV drugs purchased under this centrally-funded Track 1 activity will be supplemented by ARV drugs purchased for the USG Haiti program by PFSCM under the PEPFAR country funds in order to ensure a full year's supply of drugs for all patients at the eight sites in the AIDSRelief network.